Condition: Diabetic Foot Ulcer · Venous Leg Ulcer · Ulcer Foot · Sponsor: Stability Biologics
This is a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers.
This description comes directly from the study's public registry record.
Bennett M Rogers · 888-960-1343 · brogers@serenagroups.com
Thomas Serena, MD · 814-688-4000 · serena@serenagroups.com
Always discuss trial participation with your own doctor first.
| Cutting Edge Research | Circleville, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06560502